Results from RCTs in Sclerotherapy: European Guidelines for Sclerotherapy in Chronic Venous Disorders*-Reference-Cited by-同舟云学术

Results from RCTs in Sclerotherapy: European Guidelines for Sclerotherapy in Chronic Venous Disorders*

Published:2014-05 Issue:1_suppl Volume:29 Page:39-44
ISSN:0268-3555
Container-title:Phlebology: The Journal of Venous Disease
language:en
Short-container-title:Phlebology

Author:

Pannier F¹,Rabe E²,

Affiliation:

1. Department of Dermatology, University of Cologne, Cologne & Private Practice Dermatology and Phlebology Bonn, Germany

2. Department of Dermatology, University of Bonn, Bonn, Germany

Abstract

Aim Sclerotherapy is the targeted chemical ablation of varicose veins by intravenous injection of a liquid or foamed sclerosing drug. The treated veins may be intradermal, subcutaneous, and/or transfascial as well as superficial and deep in venous malformations. The aim of this guideline is to give evidence-based recommendations for liquid and foam sclerotherapy. Methods This guideline was drafted on behalf of 23 European Phlebological Societies during a Guideline Conference on 7th–10th May 2012 in Mainz. The conference was organized by the German Society of Phlebology. Results This guideline focuses on the two sclerosing drugs which are licensed in the majority of the European countries, Polidocanol (POL) and Sodium tetradecyl sulphate (STS). Other sclerosants are not discussed in detail. In this paper the results from recent RCTs in sclerotherapy are reviewed.

Publisher

SAGE Publications

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

http://journals.sagepub.com/doi/pdf/10.1177/0268355514528133

Reference60 articles.

1. Grading Strength of Recommendations and Quality of Evidence in Clinical Guidelines

2. Guidelines of care for sclerotherapy treatment of varicose and telangiectatic leg veins

3. Guidelines for Sclerotherapy of Varicose Veins (ICD 10: I83.0, I83.1, I83.2, and I83.9)

4. Comparison of 1% and 3% Polidocanol Foam in Ultrasound Guided Sclerotherapy of the Great Saphenous Vein: A Randomised, Double-Blind Trial with 2 Year-Follow-up. “The 3/1 Study”

5. Ultrasound-Guided Foam Sclerotherapy for Treating Incompetent Great Saphenous Veins—Results of 5 Years of Analysis and Morphologic Evolvement Study

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The rare complication of vascular malformations of the limb after sclerotherapy: a report of 3 cases and brief literature review;BMC Pediatrics;2023-04-28

2. S2k guidelines: diagnosis and treatment of varicose veins;Der Hautarzt;2022-04-19

3. Ultrasound-guided foam sclerotherapy is safe and effective in the management of superficial venous insufficiency of the lower extremity;Journal of Vascular Surgery: Venous and Lymphatic Disorders;2021-07

4. Clinical outcome of short-term compression after sclerotherapy for telangiectatic varicose veins;Journal of Vascular Surgery: Venous and Lymphatic Disorders;2021-03

5. Efficacy and safety of glucose, glucose and polidocanol combination, liquid polidocanol and polidocanol foam in the treatment of reticular veins: A randomized study in rabbits;Phlebology: The Journal of Venous Disease;2020-10-08